1. Home
  2. MOVE vs EQ Comparison

MOVE vs EQ Comparison

Compare MOVE & EQ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Movano Inc.

MOVE

Movano Inc.

N/A

Current Price

$10.83

Market Cap

297.4M

Sector

Health Care

ML Signal

N/A

Logo Equillium Inc.

EQ

Equillium Inc.

N/A

Current Price

$2.01

Market Cap

140.1M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
MOVE
EQ
Founded
2018
2017
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Electromedical & Electrotherapeutic Apparatus
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
297.4M
140.1M
IPO Year
2021
2018

Fundamental Metrics

Financial Performance
Metric
MOVE
EQ
Price
$10.83
$2.01
Analyst Decision
Strong Buy
Analyst Count
0
3
Target Price
N/A
$8.00
AVG Volume (30 Days)
299.3K
385.8K
Earning Date
04-08-2026
05-25-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$433,000.00
$41,095,000.00
Revenue This Year
$1,460.71
N/A
Revenue Next Year
$96.77
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.52
$0.76
52 Week High
$34.87
$3.54

Technical Indicators

Market Signals
Indicator
MOVE
EQ
Relative Strength Index (RSI) 42.90 40.88
Support Level $7.52 $1.97
Resistance Level $12.08 $2.58
Average True Range (ATR) 1.74 0.18
MACD -0.04 -0.02
Stochastic Oscillator 22.17 5.88

Price Performance

Historical Comparison
MOVE
EQ

About MOVE Movano Inc.

Corvex Inc is an AI cloud computing company that provides computing infrastructure for artificial intelligence workloads, including GPU-accelerated computing, confidential computing, and inference services. Its offerings are used by government and enterprise customers, including those with regulated workloads, to support the deployment and operation of AI models and data processing systems. The company generates revenue from the sale of Wellness Rings, portable chargers and charging cables, ring sizers, and mobile applications.

About EQ Equillium Inc.

Equillium Inc is a biotechnology innovator developing novel therapies to treat severe autoimmune and inflammatory disorders with the mission to develop life-changing therapeutics for patients. It primary goal is to advance EQ504, a novel aryl hydrocarbon receptor, or AhR, modulator, into and through clinical development. The Company operates through a single operating and reportable segment focused on the business of developing novel therapies to treat severe autoimmune and inflammatory disorders, with the mission to develop life-changing therapeutics for patients. The Company manages all business activities on a consolidated basis.

Share on Social Networks: